{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T04:17:08Z","timestamp":1777781828017,"version":"3.51.4"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,1,10]],"date-time":"2018-01-10T00:00:00Z","timestamp":1515542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,1,10]],"date-time":"2018-01-10T00:00:00Z","timestamp":1515542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Corticotropin-releasing factor signaling through CRF receptor type 1 (CRF<jats:sub>1<\/jats:sub>) has been shown to contribute to learning and memory function. A haplotype of alleles T-A-T in a set of common polymorphisms in the gene encoding for CRF<jats:sub>1<\/jats:sub>(<jats:italic>CRHR1<\/jats:italic>) has been associated with both depression vulnerability and alterations in cognitive functioning. The present study investigated the relations between the TAT haplotype and specific symptoms of depression, self-reported ruminative behaviors, and neuropsychological performance on a learning and memory task. Participants were adults with major depression with and without psychotic features (<jats:italic>N<\/jats:italic>\u2009=\u2009406). Associations were examined between TAT haplotype and endorsement of depression symptoms from diagnostic interviews, scores on the rumination response scale (RRS), and verbal memory performance on the California Verbal Learning Test-II (CVLT-II). All analyses included depression subtype, age, and sex as covariates; CVLT-II analyses also included evening cortisol levels. Across the entire sample, carriers of more copies of the TAT haplotype reported greater endorsement of the symptom describing difficulty concentrating and making decisions. In separate subsamples, TAT homozygotes had higher rumination scores on the RRS, both brooding and reflection subscales, and more TAT copies were associated with poorer CVLT-II performance in both total learning and free recall trials. These data demonstrate that the<jats:italic>CRHR1<\/jats:italic>TAT haplotype is associated with cognitive features of depression including difficulty with decision-making, higher rumination, and poorer learning and memory. It will be important in future research to identify the specific molecular mechanisms for CRF<jats:sub>1<\/jats:sub>signaling that contribute to depression-related cognitive dysfunction.<\/jats:p>","DOI":"10.1038\/s41398-017-0051-0","type":"journal-article","created":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T15:55:18Z","timestamp":1515426918000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Corticotropin-releasing factor 1 receptor haplotype and cognitive features of major depression"],"prefix":"10.1038","volume":"8","author":[{"given":"Elena Goetz","family":"Davis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Keller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joachim","family":"Hallmayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather Ryan","family":"Pankow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Greer M.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian H.","family":"Gotlib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan F.","family":"Schatzberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,1,10]]},"reference":[{"key":"51_CR1","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S1471-4892(01)00117-5","volume":"2","author":"JMHM Reul","year":"2002","unstructured":"Reul, J. M. H. M. & Holsboer, F. Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression. Curr. Opin. Pharmacol. 2, 23\u201333 (2002).","journal-title":"Curr. Opin. Pharmacol."},{"key":"51_CR2","unstructured":"Nemeroff, C.B. The corticotropin-releasing factor (CRF) hypothesis of depression: new findings and new directions. Mol. Psychiatry. 1, 336\u2013342 (1996)."},{"key":"51_CR3","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1038\/mp.2009.141","volume":"15","author":"EB Binder","year":"2010","unstructured":"Binder, E. B. & Nemeroff, C. B. The CRF system, stress, depression and anxiety-insights from human genetic studies. Mol. Psychiatry 15, 574\u2013588 (2010).","journal-title":"Mol. Psychiatry"},{"key":"51_CR4","doi-asserted-by":"publisher","first-page":"8777","DOI":"10.1073\/pnas.91.19.8777","volume":"91","author":"E Potter","year":"1994","unstructured":"Potter, E. et al. Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary. Proc. Natl Acad. Sci. USA 91, 8777\u20138781 (1994).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"51_CR5","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1046\/j.1432-1327.1998.2580078.x","volume":"258","author":"MR Palchaudhuri","year":"1998","unstructured":"Palchaudhuri, M. R. et al. Corticotropin-releasing factor receptor type 1 from Tupaia belangeri--cloning, functional expression and tissue distribution. Eur. J. Biochem. 258, 78\u201384 (1998).","journal-title":"Eur. J. Biochem."},{"key":"51_CR6","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/0165-6147(96)81594-X","volume":"17","author":"DT Chalmers","year":"1996","unstructured":"Chalmers, D. T., Lovenberg, T. W., Grigoriadis, D. E., Behan, D. P. & De Souza, E. B. Corticotrophin-releasing factor receptors: from molecular biology to drug design. Trends Pharmacol. Sci. 17, 166\u2013172 (1996).","journal-title":"Trends Pharmacol. Sci."},{"key":"51_CR7","doi-asserted-by":"publisher","first-page":"13005","DOI":"10.1523\/JNEUROSCI.1784-10.2010","volume":"30","author":"AS Ivy","year":"2010","unstructured":"Ivy, A. S. et al. Hippocampal dysfunction and cognitive impairments provoked by chronic early-life stress involve excessive activation of CRH receptors. J. Neurosci. 30, 13005\u201313015 (2010).","journal-title":"J. Neurosci."},{"key":"51_CR8","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.nbd.2011.01.020","volume":"42","author":"XD Wang","year":"2011","unstructured":"Wang, X.-D. et al. Forebrain CRHR1 deficiency attenuates chronic stress-induced cognitive deficits and dendritic remodeling. Neurobiol. Dis. 42, 300\u2013310 (2011).","journal-title":"Neurobiol. Dis."},{"key":"51_CR9","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.neuroscience.2007.10.001","volume":"150","author":"DT Hubbard","year":"2007","unstructured":"Hubbard, D. T., Nakashima, B. R., Lee, I. & Takahashi, L. K. Activation of basolateral amygdala corticotropin-releasing factor 1 receptors modulates the consolidation of contextual fear. Neuroscience 150, 818\u2013828 (2007).","journal-title":"Neuroscience"},{"key":"51_CR10","doi-asserted-by":"publisher","first-page":"13908","DOI":"10.1073\/pnas.212504599","volume":"99","author":"B Roozendaal","year":"2002","unstructured":"Roozendaal, B., Brunson, K. L., Holloway, B. L., McGaugh, J. L. & Baram, T. Z. Involvement of stress-released corticotropin-releasing hormone in the basolateral amygdala in regulating memory consolidation. Proc. Natl Acad. Sci. USA 99, 13908\u201313913 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"51_CR11","doi-asserted-by":"publisher","first-page":"2733","DOI":"10.1038\/npp.2016.85","volume":"41","author":"S Hupalo","year":"2016","unstructured":"Hupalo, S. & Berridge, C. W. Working memory impairing actions of corticotropin-releasing factor (CRF) neurotransmission in the prefrontal cortex. Neuropsychopharmacology 41, 2733\u20132740 (2016).","journal-title":"Neuropsychopharmacology"},{"key":"51_CR12","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1001\/archgenpsychiatry.2007.26","volume":"65","author":"RG Bradley","year":"2008","unstructured":"Bradley, R. G. et al. Influence of child abuse on adult depression. Arch. Gen. Psychiatry 65, 190\u2013200 (2008).","journal-title":"Arch. Gen. Psychiatry"},{"key":"51_CR13","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/ajmg.b.31052","volume":"153","author":"KJ Ressler","year":"2010","unstructured":"Ressler, K. J. et al. Polymorphisms in CRHR1 and the serotonin transporter loci: gene x gene x environment interactions on depressive symptoms. Am. J. Med. Genet. Part B 153, 812\u2013824 (2010).","journal-title":"Am. J. Med. Genet. Part B"},{"key":"51_CR14","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1001\/archgenpsychiatry.2009.114","volume":"66","author":"G Polanczyk","year":"2009","unstructured":"Polanczyk, G. et al. Protective effect of CRHR1 gene variants on the development of adult depression following childhood maltreatment. Arch. Gen. Psychiatry 66, 978\u2013985 (2009).","journal-title":"Arch. Gen. Psychiatry"},{"key":"51_CR15","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1002\/ajmg.b.31131","volume":"153B","author":"HJ Grabe","year":"2010","unstructured":"Grabe, H. J. et al. Childhood maltreatment, the corticotropin-releasing hormone receptor gene and adult depression in the general population. Am. J. Med. Genet. Part B 153B, 1483\u20131493 (2010).","journal-title":"Am. J. Med. Genet. Part B"},{"key":"51_CR16","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/mp.2013.129","volume":"19","author":"AF Schatzberg","year":"2014","unstructured":"Schatzberg, A. F. et al. HPA axis genetic variation, cortisol and psychosis in major depression. Mol. Psychiatry 19, 220\u2013227 (2014).","journal-title":"Mol. Psychiatry"},{"key":"51_CR17","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.psyneuen.2014.02.002","volume":"43","author":"JA Sumner","year":"2014","unstructured":"Sumner, J. A., McLaughlin, K. A., Walsh, K., Sheridan, M. A. & Koenen, K. C. CRHR1 genotype and history of maltreatment predict cortisol reactivity to stress in adolescents. Psychoneuroendocrinology 43, 71\u201380 (2014).","journal-title":"Psychoneuroendocrinology"},{"key":"51_CR18","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.biopsych.2009.05.012","volume":"66","author":"AR Tyrka","year":"2009","unstructured":"Tyrka, A. R. et al. Interaction of childhood maltreatment with the corticotropin-releasing hormone receptor gene: Effects on hypothalamic-pituitary-adrenal axis reactivity. Biol. Psychiatry 66, 681\u2013685 (2009).","journal-title":"Biol. Psychiatry"},{"key":"51_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuroscience.2012.10.056","volume":"229","author":"HI Sheikh","year":"2013","unstructured":"Sheikh, H. I., Kryski, K. R., Smith, H. J., Hayden, E. P. & Singh, S. M. Corticotropin-releasing hormone system polymorphisms are associated with children\u2019s cortisol reactivity. Neuroscience 229, 1\u201311 (2013).","journal-title":"Neuroscience"},{"key":"51_CR20","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1017\/S0954579411000599","volume":"23","author":"D Cicchetti","year":"2011","unstructured":"Cicchetti, D., Rogosch, F. A. & Oshri, A. Interactive effects of CRHR1, 5-HTTLPR, and child maltreatment on diurnal cortisol regulation and internalizing symptomatology. Dev. Psychopathol. 23, 1125\u20131138 (2011).","journal-title":"Dev. Psychopathol."},{"key":"51_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/neuro.08.041.2009","volume":"3","author":"C Heim","year":"2009","unstructured":"Heim, C. et al. Effect of childhood trauma on adult depression and neuroendocrine function: sex-specific moderation by CRH receptor 1 gene. Front Behav. Neurosci. 3, 1\u201310 (2009).","journal-title":"Front Behav. Neurosci."},{"key":"51_CR22","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1111\/j.1469-7610.2011.02404.x","volume":"52","author":"CG DeYoung","year":"2011","unstructured":"DeYoung, C. G., Cicchetti, D. & Rogosch, F. A. Moderation of the association between childhood maltreatment and neuroticism by the corticotropin-releasing hormone receptor 1 gene. J. Child. Psychol. Psychiatry 52, 898\u2013906 (2011).","journal-title":"J. Child. Psychol. Psychiatry"},{"key":"51_CR23","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.euroneuro.2012.06.002","volume":"23","author":"M Laucht","year":"2013","unstructured":"Laucht, M. et al. Interactive effects of corticotropin-releasing hormone receptor 1 gene and childhood adversity on depressive symptoms in young adults: findings from a longitudinal study. Eur. Neuropsychopharmacol. 23, 358\u2013367 (2013).","journal-title":"Eur. Neuropsychopharmacol."},{"key":"51_CR24","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1016\/j.biopsych.2014.04.016","volume":"76","author":"P Fuge","year":"2014","unstructured":"Fuge, P. et al. Interaction of early life stress and corticotropin-releasing hormone receptor gene: Effects on working memory. Biol. Psychiatry 76, 888\u2013894 (2014).","journal-title":"Biol. Psychiatry"},{"key":"51_CR25","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.copsyc.2015.01.004","volume":"4","author":"ML Woody","year":"2015","unstructured":"Woody, M. L. & Gibb, B. E. Integrating NIMH Research Domain Criteria (RDoC) into depression research. Curr. Opin. Psychol. 4, 6\u201312 (2015).","journal-title":"Curr. Opin. Psychol."},{"key":"51_CR26","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.jpsychires.2012.10.014","volume":"47","author":"S Guillaume","year":"2013","unstructured":"Guillaume, S. et al. HPA axis genes may modulate the effect of childhood adversities on decision-making in suicide attempters. J. Psychiatry Res. 47, 259\u2013265 (2013).","journal-title":"J. Psychiatry Res."},{"key":"51_CR27","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/gbb.12032","volume":"12","author":"LA Ray","year":"2013","unstructured":"Ray, L. A. et al. The CRHR1 gene, trauma exposure, and alcoholism risk: a test of G x E effects. Genes Brain Behav. 12, 361\u2013369 (2013).","journal-title":"Genes Brain Behav."},{"key":"51_CR28","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1002\/ajmg.b.31243","volume":"156","author":"HR Kranzler","year":"2011","unstructured":"Kranzler, H. R. et al. A CRHR1 haplotype moderates the effect of adverse childhood experiences on lifetime risk of major depressive episode in African-American women. Am. J. Med. Genet. Part B 156, 960\u2013968 (2011).","journal-title":"Am. J. Med. Genet. Part B"},{"key":"51_CR29","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1111\/j.1530-0277.2010.01173.x","volume":"34","author":"ACH Chen","year":"2010","unstructured":"Chen, A. C. H. et al. Single-nucleotide polymorphisms in corticotropin releasing hormone receptor 1 gene (CRHR1) are associated with quantitative trait of event-related potential and alcohol dependence. Alcohol. Clin. Exp. Res. 34, 988\u2013996 (2010).","journal-title":"Alcohol. Clin. Exp. Res."},{"key":"51_CR30","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1038\/mp.2010.89","volume":"15","author":"DA Bangasser","year":"2010","unstructured":"Bangasser, D. A. et al. Sex differences in corticotropin-releasing factor receptor signaling and trafficking: potential role in female vulnerability to stress-related psychopathology. Mol. Psychiatry 15, 877\u2013904 (2010).","journal-title":"Mol. Psychiatry"},{"key":"51_CR31","unstructured":"First, M., Spitzer, R., Gibbon, M. & Williams, J. User\u2019s guide for the structured clinical interview for DSM-IV axis I disorders SCID-I: clinician version. Am. Psychiatry Pub. (1997)."},{"key":"51_CR32","first-page":"22","volume":"59","author":"DV Sheehan","year":"1998","unstructured":"Sheehan, D. V. et al. The Mini-International Neuropsychiatric Interview (M.I.N.I): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J. Clin. Psychiatry 59, 22\u201333 (1998).","journal-title":"J. Clin. Psychiatry"},{"key":"51_CR33","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","volume":"23","author":"M Hamilton","year":"1960","unstructured":"Hamilton, M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 23, 56\u201362 (1960).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"51_CR34","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1111\/j.2044-8260.1967.tb00530.x","volume":"6","author":"M Hamilton","year":"1967","unstructured":"Hamilton, M. Development of a rating scale for primary depressive illness. Br. J. Soc. Clin. Psychol. 6, 278\u2013296 (1967).","journal-title":"Br. J. Soc. Clin. Psychol."},{"key":"51_CR35","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1037\/0022-3514.61.1.115","volume":"61","author":"S Nolen-Hoeksema","year":"1991","unstructured":"Nolen-Hoeksema, S. & Morrow, J. A prospective study of depression and posttraumatic stress symptoms after a natural disaster: the 1989 Loma Prieta Earthquake. J. Pers. Soc. Psychol. 61, 115\u2013121 (1991).","journal-title":"J. Pers. Soc. Psychol."},{"key":"51_CR36","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1023\/A:1023910315561","volume":"27","author":"W Treynor","year":"2003","unstructured":"Treynor, W., Gonzalez, R. & Nolen-Hoeksema, S. Rumination reconsidered: a psychometric analysis. Cognit. Ther. Res. 27, 247\u2013259 (2003).","journal-title":"Cognit. Ther. Res."},{"key":"51_CR37","unstructured":"Delis, D. C., Kramer, J. H., Kaplan, E. & Ober, B. A. California Verbal Learning Test-2nd Edition, Adult Version, Manual. Psychological Corporation, San Antonio, TX (2000)."},{"key":"51_CR38","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.biopsych.2005.10.014","volume":"60","author":"J Keller","year":"2006","unstructured":"Keller, J. et al. Cortisol circadian rhythm alterations in psychotic major depression. Biol. Psychiatry 60, 275\u2013281 (2006).","journal-title":"Biol. Psychiatry"},{"key":"51_CR39","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.biopsych.2005.11.010","volume":"60","author":"RG Gomez","year":"2006","unstructured":"Gomez, R. G. et al. The neuropsychological profile of psychotic major depression and its relation to cortisol. Biol. Psychiatry 60, 472\u2013478 (2006).","journal-title":"Biol. Psychiatry"},{"key":"51_CR40","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1086\/319501","volume":"68","author":"M Stephens","year":"2001","unstructured":"Stephens, M., Smith, N. J. & Donnelly, P. A new statistical method for haplotype reconstruction from population data. Am. J. Hum. Genet. 68, 978\u2013989 (2001).","journal-title":"Am. J. Hum. Genet."},{"key":"51_CR41","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1001\/archpsyc.57.8.755","volume":"57","author":"Ja Posener","year":"2000","unstructured":"Posener, Ja, DeBattista, C., Williams, G. H., Chmura Kraemer, H. & Kalehzan, B. M. Schatzberg a F. 24-Hour monitoring of cortisol and corticotropin secretion in psychotic and nonpsychotic major depression. Arch. Gen. Psychiatry 57, 755\u2013760 (2000).","journal-title":"Arch. Gen. Psychiatry"},{"key":"51_CR42","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1038\/sj.mp.4001587","volume":"9","author":"J Licinio","year":"2004","unstructured":"Licinio, J. et al. Association of a corticotropin-releasing hormone receptor 1 haplotype and antidepressant treatment response in Mexican-Americans. Mol. Psychiatry 9, 1075\u20131082 (2004).","journal-title":"Mol. Psychiatry"},{"key":"51_CR43","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1176\/ajp.2007.164.6.900","volume":"164","author":"J Raskin","year":"2007","unstructured":"Raskin, J. et al. Efficacy of duloxetine on cognition, depression, and pain in elderly patients with major depressive disorder: an 8-week, double-blind, placebo-controlled trial. Am. J. Psychiatry 164, 900\u2013909 (2007).","journal-title":"Am. J. Psychiatry"},{"key":"51_CR44","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1016\/j.euroneuro.2016.09.641","volume":"26","author":"KW Miskowiak","year":"2016","unstructured":"Miskowiak, K. W., Ott, C. V., Petersen, J. Z. & Kessing, L. V. Systematic review of randomized controlled trials of candidate treatments for cognitive impairment in depression and methodological challenges in the field. Eur. Neuropsychopharmacol. 26, 1845\u20131867 (2016).","journal-title":"Eur. Neuropsychopharmacol."},{"key":"51_CR45","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1038\/npp.2015.52","volume":"40","author":"AR Mahableshwarkar","year":"2015","unstructured":"Mahableshwarkar, A. R., Zajecka, J., Jacobson, W., Chen, Y. & Keefe, R. S. A randomized, placebo-controlled, active-reference, double-blind, flexible-dose study of the efficacy of vortioxetine on cognitive function in major depressive disorder. Neuropsychopharmacology 40, 2025\u20132037 (2015).","journal-title":"Neuropsychopharmacology"},{"key":"51_CR46","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1017\/S0954579414001278","volume":"27","author":"D Cicchetti","year":"2015","unstructured":"Cicchetti, D., Toth, S. L. & Handley, E. D. Genetic moderation of interpersonal psychotherapy efficacy for low-income mothers with major depressive disorder: implications for differential susceptibility. Dev. Psychopathol. 27, 19\u201335 (2015).","journal-title":"Dev. Psychopathol."},{"key":"51_CR47","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1037\/a0017376","volume":"135","author":"J Belsky","year":"2009","unstructured":"Belsky, J. & Pluess, M. Beyond diathesis stress: differential susceptibility to environmental influences. Psychol. Bull. 135, 885\u2013908 (2009).","journal-title":"Psychol. Bull."},{"key":"51_CR48","first-page":"1","volume":"9931","author":"ML Woody","year":"2015","unstructured":"Woody, M. L. et al. Influence of maternal depression on children\u2019s brooding rumination: Moderation by CRHR1 TAT haplotype. Cogn. Emot. 30, 302\u2013314 (2015).","journal-title":"Cogn. Emot."},{"key":"51_CR49","doi-asserted-by":"crossref","unstructured":"Van Hulle, C. A., Clifford, S., Moore, M. N., Lemery-Chalfant, K., & Goldsmith, H. H. Partial replication of two rumination-related candidate gene studies. Cogn. Emot. 31, 963\u2013971 (2017).","DOI":"10.1080\/02699931.2016.1168779"},{"key":"51_CR50","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.bandc.2007.02.007","volume":"65","author":"SJ Lupien","year":"2007","unstructured":"Lupien, S. J., Maheu, F., Tu, M., Fiocco, A. & Schramek, T. E. The effects of stress and stress hormones on human cognition: Implications for the field of brain and cognition. Brain Cogn. 65, 209\u2013237 (2007).","journal-title":"Brain Cogn."},{"key":"51_CR51","first-page":"1","volume":"2","author":"J Keller","year":"2016","unstructured":"Keller, J. et al. HPA axis in major depression: cortisol, clinical symptomatology and genetic variation predict cognition. Mol. Psychiatry 2, 1\u201310 (2016).","journal-title":"Mol. Psychiatry"},{"key":"51_CR52","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.exger.2010.09.006","volume":"46","author":"MC Pardon","year":"2011","unstructured":"Pardon, M.-C. Therapeutic potential of some stress mediators in early Alzheimer\u2019s disease. Exp. Gerontol. 46, 170\u2013173 (2011).","journal-title":"Exp. Gerontol."},{"key":"51_CR53","doi-asserted-by":"publisher","first-page":"3193","DOI":"10.1172\/JCI79828","volume":"125","author":"LF Vendruscolo","year":"2015","unstructured":"Vendruscolo, L. F. et al. Glucocorticoid receptor antagonism decreases alcohol seeking in alcohol-dependent individuals. J. Clin. Invest. 125, 3193\u20133197 (2015).","journal-title":"J. Clin. Invest."},{"key":"51_CR54","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1006\/nbdi.2001.0395","volume":"8","author":"WA Pedersen","year":"2001","unstructured":"Pedersen, W. A. et al. Corticotropin-releasing hormone protects neurons against insults relevant to the pathogenesis of Alzheimer\u2019s disease. Neurobiol. Dis. 8, 492\u2013503 (2001).","journal-title":"Neurobiol. Dis."},{"key":"51_CR55","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.arr.2005.02.004","volume":"4","author":"N Bayatti","year":"2005","unstructured":"Bayatti, N. & Behl, C. The neuroprotective actions of corticotropin releasing hormone. Ageing. Res. Rev. 4, 258\u2013270 (2005).","journal-title":"Ageing. Res. Rev."},{"key":"51_CR56","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/mp.2012.198","volume":"18","author":"Y Koutmani","year":"2013","unstructured":"Koutmani, Y. et al. Corticotropin-releasing hormone exerts direct effects on neuronal progenitor cells: implications for neuroprotection. Mol. Psychiatry. 18, 300\u2013307 (2013).","journal-title":"Mol. Psychiatry."},{"key":"51_CR57","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1172\/JCI116782","volume":"92","author":"NC Vamvakopoulos","year":"1993","unstructured":"Vamvakopoulos, N. C. & Chrousos, G. P. Evidence of direct estrogenic regulation of human corticotropin-releasing hormone gene expression. Potential implications for the sexual dimophism of the stress response and immune\/inflammatory reaction. J. Clin. Invest. 92, 1896\u20131902 (1993).","journal-title":"J. Clin. Invest."},{"key":"51_CR58","doi-asserted-by":"publisher","first-page":"ra53","DOI":"10.1126\/scisignal.2003926","volume":"6","author":"S Lal","year":"2013","unstructured":"Lal, S. et al. Estrogen Alters the Splicing of Type 1 Corticotropin-Releasing Hormone Receptor in Breast Cancer Cells. Sci. Signal. 6, ra53\u2013ra53 (2013).","journal-title":"Sci. Signal."},{"key":"51_CR59","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.maturitas.2008.09.024","volume":"61","author":"KM Edwards","year":"2008","unstructured":"Edwards, K. M. & Mills, P. J. Effects of estrogen versus estrogen and progesterone on cortisol and interleukin-6. Maturitas. 61, 330\u2013333 (2008).","journal-title":"Maturitas."}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-017-0051-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-017-0051-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-017-0051-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T10:27:38Z","timestamp":1719743258000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-017-0051-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,10]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["51"],"URL":"https:\/\/doi.org\/10.1038\/s41398-017-0051-0","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,10]]},"assertion":[{"value":"30 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Schatzberg has been a consultant for Alkermes, Clintara, Forum (EnVivo), Lundbeck\/Takeda, McKinsey, Myriad Genetics, Maurex, Neuronetics, and Sunovion; and has equity in Amestix, Delpor, Gilead, Incyte, Merck, Neurocrine, Seattle Genetics, Titan, Xhale, and Corcept Therapeutics, Inc., where he is also the co-founder. He has received grant support from Janssen and is a named inventor on pharmacogenetic and antiglucocorticoid use patents on prediction of antidepressant response. Dr. Greer Murphy has been a consultant for Brain Resource, Ltd. The remaining authors declare that they have no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5"}}